Lataa...
Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO
Background: Hemolytic uraemic syndrome (HUS) is progressive renal failure disease and determination of their quality of life (QoL) on the basis of patient-reported outcomes (PROs) are becoming increasingly important in the economic evaluations for its treatment with eculizumab (ECU). Aim: To perform...
Tallennettuna:
| Julkaisussa: | Ren Fail |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6014301/ https://ncbi.nlm.nih.gov/pubmed/29363392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2018.1427110 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|